PILOTTO, Sara
PILOTTO, Sara
DIPARTIMENTO DI INGEGNERIA PER LA MEDICINA DI INNOVAZIONE
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.001 secondi).
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models
2018-01-01 Gkountakos, A; Pilotto, S; Simbolo, M; Vicentini, C; Mafficini, A; Del Curatolo, A; Scarpa, A; Tortora, G; Corbo, V; Bria, E
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations
2018-01-01 Pilotto, S; Grizzi, G; Sperduti, I; Simbolo, M; Vicentini, C; Caliò, A; Caccese, M; Mafficini, A; Carbognin, L; Corbo, V; Gkountakos, A; Santo, A; Infante, M; Brunelli, M; Scarpa, A; Tortora, G; Bria, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models | 1-gen-2018 | Gkountakos, A; Pilotto, S; Simbolo, M; Vicentini, C; Mafficini, A; Del Curatolo, A; Scarpa, A; Tortora, G; Corbo, V; Bria, E | |
| Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations | 1-gen-2018 | Pilotto, S; Grizzi, G; Sperduti, I; Simbolo, M; Vicentini, C; Caliò, A; Caccese, M; Mafficini, A; Carbognin, L; Corbo, V; Gkountakos, A; Santo, A; Infante, M; Brunelli, M; Scarpa, A; Tortora, G; Bria, E |